You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 18, 2025

List of Excipients in API zaleplon


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing zaleplon

Glossary

Excipients in ANDA-approved (generic) drugs containing zaleplon

Detailed excipient profiles for zaleplon

Excipient focus: ALUMINUM OXIDE

zaleplon drug variants not containing ALUMINUM OXIDE

Excipient focus: ANHYDROUS LACTOSE

zaleplon drug variants not containing ANHYDROUS LACTOSE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

zaleplon drug variants containing CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

zaleplon drug variants not containing COLLOIDAL SILICON DIOXIDE

Excipient focus: D&C YELLOW NO. 10

zaleplon drug variants not containing D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 1

zaleplon drug variants containing FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

zaleplon drug variants not containing FD&C BLUE NO. 2

Excipient focus: FD&C GREEN NO. 3

zaleplon drug variants containing FD&C GREEN NO. 3

zaleplon drug variants not containing FD&C GREEN NO. 3

Excipient focus: FD&C RED NO. 40

zaleplon drug variants containing FD&C RED NO. 40

zaleplon drug variants not containing FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

zaleplon drug variants containing FD&C YELLOW NO. 5

zaleplon drug variants not containing FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

zaleplon drug variants not containing FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE BLACK

zaleplon drug variants not containing FERRIC OXIDE BLACK

Excipient focus: FERROSOFERRIC OXIDE

zaleplon drug variants containing FERROSOFERRIC OXIDE

zaleplon drug variants not containing FERROSOFERRIC OXIDE

Excipient focus: GELATIN

zaleplon drug variants containing GELATIN

Excipient focus: LACTOSE

zaleplon drug variants not containing LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

zaleplon drug variants containing LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

zaleplon drug variants containing MAGNESIUM STEARATE

Excipient focus: PROPYLENE GLYCOL

zaleplon drug variants not containing PROPYLENE GLYCOL

Excipient focus: SHELLAC

zaleplon drug variants containing SHELLAC

zaleplon drug variants not containing SHELLAC

Excipient focus: SILICON DIOXIDE

zaleplon drug variants containing SILICON DIOXIDE

Excipient focus: SILICON DIOXIDE, COLLOIDAL

zaleplon drug variants not containing SILICON DIOXIDE, COLLOIDAL

Excipient focus: SODIUM LAURYL SULFATE

zaleplon drug variants containing SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

zaleplon drug variants containing STARCH, CORN

Excipient focus: STEARIC ACID

zaleplon drug variants not containing STEARIC ACID

Excipient focus: TITANIUM DIOXIDE

zaleplon drug variants containing TITANIUM DIOXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group